Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting, 26970 [E6-7020]

Download as PDF 26970 Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices to better describe geographic variation in cancer incidence throughout the country and provide incidence data on minority populations and rare cancers to further plan and evaluate state and national cancer control and prevention efforts. Therefore, CDCs, NCCDPHP, Division of Cancer Prevention and Control proposes to continue to aggregate existing cancer incidence data from year for which the cancer registry collected data with the assistance of NPCR funds (e.g., 1995) through to 12 months past the close of the most recent diagnosis year (e.g., 2004). NCCPHP is requesting a 3-year clearance for this project. There are no costs to respondents except their time to participate in the survey. states funded by the National Program of Cancer Registries into a national surveillance system. These data are already collected and aggregated at the state level. Thus the additional burden for the states is small. Funded states are asked to continue to report cancer incidence data to CDC on an annual basis. Each state is requested to report a cumulative file containing incidence data from the first diagnosis ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per resondent Number of respondents Respondents Average burden per response (in hours) Total burden hours States, Territories, and the District of Columbia (Cancer Registries) ............. 63 1 2 126 Total .......................................................................................................... ........................ ........................ ........................ 126 Dated: May 3, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–7019 Filed 5–8–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting mstockstill on PROD1PC68 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC). Dates and Times: June 5, 2006, 9 a.m. to 5 p.m. June 6, 2006, 8:30 a.m. to 3 p.m. Place: Four Points Sheraton Downtown, Franklin AB Room, 1201 K Street, NW., Washington, DC 20005. Status: The meeting will be open to the public with attendance limited to space availability. Purpose: The Advisory Committee provides advice and recommendations concerning the grants and projects authorized under the Heritable Disorders Program and technical information to develop policies and priorities for this program. The Heritable Disorders Program was established to enhance the ability of State and local health agencies to provide for newborn and child screening, counseling and health care services for newborns and children having or at risk for heritable disorders. The Committee was established specifically to advise and guide the Secretary regarding the most appropriate application of universal newborn VerDate Aug<31>2005 15:42 May 08, 2006 Jkt 208001 screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. Agenda: The meeting will be devoted to the decision making process for candidate conditions on the Newborn Screening Panel as well as the continued work and reports by the Committee’s subcommittees on laboratory standards and procedures, follow-up treatment, education and training. Proposed agenda items are subject to change. Time will be provided each day for public comment. Individuals who wish to provide public comment or who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACHDGDNC Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact information provided below). Contact Person: Anyone interested in obtaining a roster of members or other relevant information should write or contact Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–1080. Information on the Advisory Committee is available at http:// mchb.hrsa.gov/programs/genetics/committee. Dated: May 3, 2006. Tina M. Cheatham, Director, Division of Policy Review and Coordination. [FR Doc. E6–7020 Filed 5–8–06; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Tribal Management Grant Program Announcement Type: New Discretionary Funding Cycle for Fiscal Year 2007. Funding Announcement Number: HHS–2007–IHS–TMP–0001. Catalog of Federal Domestic Assistance Number: 93.228. Key Dates: Training: Application Requirements Session: May 10–11 and June 14–15, 2006; Grantwriting Session: May 22–26, 2006; Application Deadline Date: August 4, 2006; Review Date: October 2–6, 2006; Application Notification: November 13, 2006; Earliest Anticipated Start Date: January 1, 2007. I. Funding Opportunity Description The Indian Health Service (IHS) announces competitive grant applications for the Tribal Management Grant (TMG) Program. This program is authorized under section 103(b)(2) and section 103(e) of the Indian SelfDetermination and Education Assistance Act, Public Law 93–638, as amended. The TMG Program is described at 93.228 in the Catalog of Federal Domestic Assistance. The TMG program is a national competitive discretionary grant program pursuant to 45 CFR part 75 and 45 CFR part 92 established to assist Federallyrecognized Tribes and Triballysanctioned Tribal organizations in assuming all or part of existing IHS programs, services, functions, and activities (PSFA) through a Title I contract and to assist established Title I contractors and Title V compactors to E:\FR\FM\09MYN1.SGM 09MYN1

Agencies

[Federal Register Volume 71, Number 89 (Tuesday, May 9, 2006)]
[Notices]
[Page 26970]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7020]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders and Genetic Diseases in 
Newborns and Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Committee on Heritable Disorders and Genetic 
Diseases in Newborns and Children (ACHDGDNC).
    Dates and Times: June 5, 2006, 9 a.m. to 5 p.m. June 6, 2006, 
8:30 a.m. to 3 p.m.
    Place: Four Points Sheraton Downtown, Franklin AB Room, 1201 K 
Street, NW., Washington, DC 20005.
    Status: The meeting will be open to the public with attendance 
limited to space availability.
    Purpose: The Advisory Committee provides advice and 
recommendations concerning the grants and projects authorized under 
the Heritable Disorders Program and technical information to develop 
policies and priorities for this program. The Heritable Disorders 
Program was established to enhance the ability of State and local 
health agencies to provide for newborn and child screening, 
counseling and health care services for newborns and children having 
or at risk for heritable disorders. The Committee was established 
specifically to advise and guide the Secretary regarding the most 
appropriate application of universal newborn screening tests, 
technologies, policies, guidelines and programs for effectively 
reducing morbidity and mortality in newborns and children having or 
at risk for heritable disorders.
    Agenda: The meeting will be devoted to the decision making 
process for candidate conditions on the Newborn Screening Panel as 
well as the continued work and reports by the Committee's 
subcommittees on laboratory standards and procedures, follow-up 
treatment, education and training.
    Proposed agenda items are subject to change.
    Time will be provided each day for public comment. Individuals 
who wish to provide public comment or who plan to attend the meeting 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the ACHDGDNC 
Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact 
information provided below).
    Contact Person: Anyone interested in obtaining a roster of 
members or other relevant information should write or contact 
Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health 
Bureau, Health Resources and Services Administration, Room 18A-19, 
Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, 
Telephone (301) 443-1080. Information on the Advisory Committee is 
available at http://mchb.hrsa.gov/programs/genetics/committee.

    Dated: May 3, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-7020 Filed 5-8-06; 8:45 am]
BILLING CODE 4165-15-P